Development
Core Scientific, Inc.
CORZ
$12.19
$0.262.18%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -195.69M | -41.15M | 2.04M | -11.69M | -434.85M |
| Total Depreciation and Amortization | 30.94M | 24.47M | 20.75M | 20.29M | 69.13M |
| Total Amortization of Deferred Charges | 752.00K | -- | -- | -- | 963.00K |
| Total Other Non-Cash Items | -79.76M | -67.91M | -83.50M | -105.46M | 285.26M |
| Change in Net Operating Assets | 265.47M | 90.02M | 78.75M | 116.80M | 195.48M |
| Cash from Operations | 21.70M | 5.43M | 18.04M | 19.94M | 115.99M |
| Capital Expenditure | -11.65M | -2.74M | -235.00K | -1.54M | -140.23M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 14.00M | -- | -- | -- | -- |
| Other Investing Activities | 7.00K | -126.00K | -384.00K | -330.00K | 748.00K |
| Cash from Investing | 2.36M | -2.87M | -619.00K | -1.87M | -139.48M |
| Total Debt Issued | -- | -- | -- | -- | 45.17M |
| Total Debt Repaid | -18.30M | -15.38M | -9.95M | -1.02M | -16.59M |
| Issuance of Common Stock | -- | -- | -- | -- | 25.05M |
| Repurchase of Common Stock | -- | -- | -- | -- | -19.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -15.52M |
| Cash from Financing | -18.30M | -15.38M | -9.95M | -1.02M | 38.09M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.77M | -12.82M | 7.47M | 17.05M | 14.60M |